Eligible patients were enrolled in the study between February 2019 and December 2021 after giving informed consent. They were discharged from the cardiac surgery department and referred to the rehabilitation ward for a 4–5 weeks’ stay. Training took place 6 times a week and lasted for 60 min. The rehabilitation program consisted of: endurance training, general fitness exercises (dynamic, stretching, coordination, balance) with elements of resistance exercises. Interval endurance training on cycle ergometer loads was determined according to cardiopulmonary exercise test (CPET) results. ECG and saturation were monitored. The rehabilitation department had contact with the attending physician and the emergency department. The training was interrupted if the patient experienced excessive fatigue, shortness of breath, chest pains, arrhythmia, headaches, as well as if the device alarm signals and sudden changes in pump parameters occurred. Before the start of rehabilitation (study 1) and after its completion (study 2), all patients underwent: 1) cardiopulmonary exercise testing (CPET, peak VO2, peak VO2%, VE/VCO2 slope, load, Borg scale evaluation); 2) 6-minute walking test (6-MWT); 3) testing of the grip strength of the right and left hands (kilograms); 4) lower limb muscle strength test – sit to stand test within 30 s; 5) the test assessing complex coordination and the risk of falling (Up&Go test) and 6) Fall Skip test used to assess the risk of falls. Patients’ risk of falls was determined based on the results obtained for each component. All patients had regular psychological support. The study was supported by the State Committee for Scientific Research grant (STRATEGMED2/266798/15/NCBIR/2015). Bioethical Committee approval was issued on April 2, 2019 (IK-NPIA-0021-55/1784/2019).
Hypertrophic cardiomyopathy (HCM) is the most common congenital disease increasing the risk of sudden cardiac death. For many years, HCM patients were excluded from exercise training. However, there are data showing that patients with HCM undergoing supervised exercise training could improve physical performance without serious adverse events. A project was designed as a randomized clinical trial to assess the effectiveness and safety of hybrid cardiac rehabilitation (HCR)—a combination of hospital-based cardiac rehabilitation (1 month) with a new form of home-based telemonitored cardiac rehabilitation (2 months) in HCM patients without left ventricular (LV) outflow tract obstruction and preserved systolic function. Sixty patients who fulfil the inclusion criteria have been randomly assigned (1:1) to either HCR plus usual care (training group) or usual care only (control group). The primary endpoint is a functional capacity evaluated by peak oxygen uptake (pVO2). Secondary endpoints include workload time during the cardiopulmonary exercise testing, a six-minute walk test distance, NT-pro BNP level, echocardiographic parameters of the left ventricular diastolic function (E/A, E/e’, myocardial strain rate), right ventricular systolic pressure, a gradient in the LV outflow tract, and quality of life. The tertiary analysis includes safety, acceptance and adherence to the HCR program. Our research will provide innovative data on the effectiveness and safety of hybrid cardiac rehabilitation in HCM patients without LV outflow tract obstruction and preserved systolic function. Clinical trials registry: ClinicalTrials.gov Identifier NCT03178357.